Translate the data on this (today's sec release) Seems VERY positive and with a cash run into 2024 on worst case basis.

Approved, best in class drug with a huge market and a nice pile of cash, it checks every box.

Amazing positive news from the TGTX 20221229 conference call, FDA approved, 🚨🔥🚨 Ublituximab Briumvi: 1) No need for additional funds, no offering, no need for capital raise, because 220 million in cash reserves expected to last until mid 2024.

$TGTX Plenty of cash on hand and commercialization up and coming.

A massive cash infusion would be perfect here. .

$HTGM A penny with cash and increasing revenue.

And no silent dilutions like avxl , reason cash stays steady 🐀🤦🏻‍♂️🤦🏻‍♂️🤦🏻‍♂️😂😂

Strong cash runway for 4 years

$AVXL wow enough cash for 4yrs

Best part some of their studies/trials are sponsored ie:Michael J Fox Foundation for Parkinsons, company says with the $150mm in cash that was on the balance sheet at quarter end is sufficient enough to take them through the next 4 years.

$AVXL I will be working the weekend to gather more cash and buy more.

Like lighting cash on 🔥

another conference reharshing the same old stuff in front of new investors, confirming that he needs cash and plans to dilute and no collaborations or deals are close. Amazing!!

$AVXL wish I had more cash to buy more !!

$BXRX Debt free 3 bucks easy! !

Company doubled in size and reduced cash burn with no risk of dilution.

3.67 cash per share and $20+ PT's. Not to mention, consistency with positive studies and data.

I still liking the pipeline and the cash gives me some confidence.